Oncologica UK

Oncologica is a world leading precision cancer medicine and Covid-19 testing and genomic sequencing laboratory based in Cambridge, UK. Our personalised cancer DNA profiling is used to precisely identify the most appropriate clinical targeted therapies and/or immunotherapies which can be used to treat patients as an alternative to chemotherapy. Our molecular Next Generation Sequencing capabilities are used to sequence tumour DNA and Covid-19/ SARS-CoV-2 for virus mutations. SARS-CoV-2 testing, and sequencing is used to identify high risk Covid-19 variants which can potentially bypass the vaccine. Oncologicas NGS DNA profiling covers 505 genes with linkage to over 750 targeted therapies to...

Precision oncology,molecular pathology,cancer treatments,tumour profiling,targeted therapies,next generation sequencing ngs,dna & rna analysis,immunotherapy,molecular tissue analytics,research and development,drug discovery,covid-19 pcr testing ,coronavirus variant sequencing,cancer dna profiling,covid-19 variant identification,travel pcr test kits,genomic cancer diagnostics,polymerase chain reaction tests,covid-19 variant detection,and genomic sequencing strategies

Oncologica uk operates in the Hospitals and health care industry.

Oncologica uk's revenue is 11m - 100m

Oncologica uk has 11 - 50 employees.